Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

George Vestermark

Adult Reconstructive Orthopaedic Surgery Indianapolis, IN Medical Doctor

NPI 1467892232 CMS profile 832082

8450 Northwest Blvd, Indianapolis, IN 46278

Open in the dashboard

General payments

$33,488

92 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, George Vestermark of Indianapolis, IN is reported in the CMS Open Payments database as having received $33,488 across 92 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $12,491 12
2023 General $15,753 18
2022 General $481 7
2021 General $1,575 23
2020 General $159 5
2019 General $3,029 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Vestermark
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to George Vestermark were reported at $0. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year George Vestermark Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $3,029 $1,416 $292–$9,336 $163
2020 $159 $647 $141–$6,474 $114
2021 $1,575 $1,073 $211–$6,497 $132
2022 $481 $1,217 $236–$6,299 $149
2023 $15,753 $1,082 $246–$6,818 $160
2024 $12,491 $1,575 $323–$8,944 $164
2025 $0 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Medical Device Business Services, Inc. $29,435 33 payments
  2. Stryker Corporation $3,193 48 payments
  3. DePuy Synthes Sales Inc. $400 5 payments
  4. Zimmer Biomet Holdings, Inc. $233 3 payments
  5. Heraeus Medical, LLC. $116 1 payment
  6. KCI USA, Inc $98 1 payment
  7. Hologic, LLC $13 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $23,952 3 payments
  2. Travel and Lodging $5,936 24 payments
  3. Food and Beverage $3,600 65 payments
Products named General payments · program years 2019–2024
  1. ACTIS Ortho-Hip $3,828 19 payments
  2. ACTIS Ortho-Hip $1,354 7 payments
  3. MAKO Knees, Hips $1,340 19 payments
  4. ATTUNE Ortho-Knee $1,319 6 payments
  5. RECLAIM $1,319 6 payments
  6. TRIATHLON $829 10 payments
  7. MAKO Knees, Hips $561 6 payments
  8. ATTUNE Ortho-Knee $231 3 payments
  9. MOBILE BEARING HIP SYSTEM $129 1 payment
  10. Persona $125 1 payment
  11. Other $783 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

487

Median for Orthopedic Surgery: 203

Drug cost

$3,878

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 47 $2,946
Cephalexin Generic 191 $388
Meloxicam Generic 123 $219
Oxycodone Hcl Generic 22 $125
Tramadol Hcl Generic 36 $104
Prednisone Generic 22 $49
Clindamycin Hcl Generic 46 $48

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$246,078

Of which drugs: $1,416

Medicare patients

566

Average age 74

Services billed

2,592

351 women, 215 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Ischemic heart disease 25%
Depression 23%
Diabetes 19%
Chronic kidney disease 19%
Osteoporosis 15%
Atrial fibrillation 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 96 611 $453

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

92 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record